- Home
- ESAB vs RGEN Comparison
ESAB vs RGEN Comparison
Compare ESAB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESAB
- RGEN
- Stock Information
- Founded
- ESAB 1904
- RGEN 1981
- Country
- ESAB United States
- RGEN United States
- Employees
- ESAB N/A
- RGEN N/A
- Industry
- ESAB Office Equipment/Supplies/Services
- RGEN Medical/Dental Instruments
- Sector
- ESAB Industrials
- RGEN Health Care
- Exchange
- ESAB Nasdaq
- RGEN Nasdaq
- Market Cap
- ESAB 6.9B
- RGEN 8.0B
- IPO Year
- ESAB N/A
- RGEN N/A
- Fundamental
- Price
- ESAB $123.10
- RGEN $118.15
- Analyst Decision
- ESAB Buy
- RGEN Buy
- Analyst Count
- ESAB 8
- RGEN 12
- Target Price
- ESAB $136.50
- RGEN $172.67
- AVG Volume (30 Days)
- ESAB 266.4K
- RGEN 819.3K
- Earning Date
- ESAB 05-01-2025
- RGEN 04-29-2025
- Dividend Yield
- ESAB 0.32%
- RGEN N/A
- EPS Growth
- ESAB 16.34
- RGEN N/A
- EPS
- ESAB 4.43
- RGEN N/A
- Revenue
- ESAB $2,729,197,000.00
- RGEN $650,429,000.00
- Revenue This Year
- ESAB N/A
- RGEN $13.93
- Revenue Next Year
- ESAB $4.79
- RGEN $14.35
- P/E Ratio
- ESAB $27.94
- RGEN N/A
- Revenue Growth
- ESAB N/A
- RGEN 4.88
- 52 Week Low
- ESAB $88.54
- RGEN $102.97
- 52 Week High
- ESAB $135.97
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- ESAB 48.77
- RGEN 38.20
- Support Level
- ESAB $127.61
- RGEN $120.11
- Resistance Level
- ESAB $130.06
- RGEN $129.42
- Average True Range (ATR)
- ESAB 2.69
- RGEN 6.02
- MACD
- ESAB -0.49
- RGEN -1.20
- Stochastic Oscillator
- ESAB 21.16
- RGEN 5.96
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.